000			02130 a2200553 4500
005			20250513232949.0
264		0	_c20010517
008			200105s 0 0 eng d
022			_a0022-1767
024	7		_a10.4049/jimmunol.166.6.3873 _2doi
040			_aNLM _beng _cNLM
100	1		_aConnelly, L
245	0	0	_aBiphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. _h[electronic resource]
260			_bJournal of immunology (Baltimore, Md. : 1950) _cMar 2001
300			_a3873-81 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xantagonists & inhibitors
650	0	4	_aArginine _xpharmacology
650	0	4	_aCell Line
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCulture Media
650	0	4	_aCyclooxygenase 2
650	0	4	_aDrug Combinations
650	0	4	_aDrug Synergism
650	0	4	_aHydrazines _xpharmacology
650	0	4	_aInflammation Mediators _xantagonists & inhibitors
650	0	4	_aInterleukin-6 _xantagonists & inhibitors
650	0	4	_aIsoenzymes _xantagonists & inhibitors
650	0	4	_aLipopolysaccharides _ximmunology
650	0	4	_aMacrophage Activation _xdrug effects
650	0	4	_aMacrophages _xdrug effects
650	0	4	_aMice
650	0	4	_aNF-kappa B _xantagonists & inhibitors
650	0	4	_aNG-Nitroarginine Methyl Ester _xpharmacology
650	0	4	_aNitric Oxide _xantagonists & inhibitors
650	0	4	_aNitric Oxide Synthase _xantagonists & inhibitors
650	0	4	_aNitric Oxide Synthase Type II
650	0	4	_aNitrogen Oxides
650	0	4	_aProstaglandin-Endoperoxide Synthases _xbiosynthesis
650	0	4	_aRNA, Messenger _xantagonists & inhibitors
650	0	4	_aTime Factors
700	1		_aPalacios-Callender, M
700	1		_aAmeixa, C
700	1		_aMoncada, S
700	1		_aHobbs, A J
773	0		_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 166 _gno. 6 _gp. 3873-81
856	4	0	_uhttps://doi.org/10.4049/jimmunol.166.6.3873 _zAvailable from publisher's website
999			_c11175865 _d11175865